Arvinas, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
ARVN on Nasdaq
Industry
Pharmaceutical Preparations
Location
395 Winchester Ave, 5 Science Park, New Haven, Connecticut

Insiders trading volume in the past year

Arvinas, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John G. Houston President and CEO, Director $51.7M -$244K -0.47% Feb 23, 2024
Sean A. Cassidy Chief Financial Officer $8.56M -$80.1K -0.93% Feb 23, 2024
Ian Taylor Chief Scientific Officer $7.87M -$80K -1.01% Feb 23, 2024
Noah Berkowitz Chief Medical Officer $4.49M Mar 18, 2024
Andrew Saik Chief Financial Officer $4.4M Jun 24, 2024
Ronald Peck Chief Medical Officer $4.11M -$79.9K -1.91% Feb 23, 2024
Randy Teel Int. Chief Financial Officer $3.11M May 21, 2024
Angela M. Cacace Chief Scientific Officer $2.83M Jun 17, 2024
Edward Moore Kennedy Jr. Director $2.63M May 29, 2024
Briggs Morrison Director $1.56M May 29, 2024
Sunil Agarwal Director $810K May 29, 2024
Everett Cunningham Director $617K May 29, 2024
Linda Bain Director $617K May 29, 2024
Leslie V. Norwalk Director $617K May 29, 2024
Laurie Smaldone Director $617K May 29, 2024
John Young Director $617K May 29, 2024
Wendy L. Dixon Director $351K Jun 15, 2023
David K. Loomis Chief Accounting Officer $276K Feb 23, 2024
Timothy M. Shannon Director $163K Jun 16, 2022
Liam Ratcliffe Director $163K Jun 16, 2022
Bradley Margus Director $163K Jun 16, 2022

Recent Insider Transactions by Companies or Individuals for Arvinas, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.